Index of /Coronavirus_(Wuhan_2019-nCov)/Covid-19_Vaccines/Pfizer_document_releases/May_2022

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf2022-05-04 15:28 7.1M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf2022-05-04 15:27 7.4M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf2022-05-04 15:26 2.3M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf2022-05-04 15:26 2.0M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf2022-05-04 15:32 2.0M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf2022-05-04 15:31 1.1M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf2022-05-04 15:29 634K 
[ ]125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf2022-05-04 15:28 6.3M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf2022-05-04 15:09 91M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf2022-05-04 14:58 1.2M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf2022-05-04 14:58 2.6M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf2022-05-04 14:56 1.5M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf2022-05-04 14:57 10M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf2022-05-04 14:49 42M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf2022-05-04 14:40 9.1M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-sap.pdf2022-05-04 15:00 2.9M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf2022-05-04 15:00 2.0M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf2022-05-04 14:59 1.5M 
[ ]125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf2022-05-04 14:59 3.7M 
[ ]125742_S1_M5_5351_bnt162-01_10010.pdf2022-05-04 15:32 1.5M 
[ ]125742_S1_M5_5351_bnt162-01_10075.pdf2022-05-04 15:32 1.6M 
[ ]125742_S1_M5_5351_bnt162-01_20116.pdf2022-05-04 15:34 1.5M 
[ ]125742_S1_M5_5351_bnt162-01_20215.pdf2022-05-04 15:33 1.6M 
[ ]125742_S1_M5_5351_bnt162-01_20242.pdf2022-05-04 15:33 1.7M 
[ ]125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf2022-05-04 14:35 65M 
[ ]125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf2022-05-04 14:30 5.4M 
[ ]125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf2022-05-04 14:29 12M 
[ ]125742_S1_M5_CRF_c4591001-1001-10011093.pdf2022-05-04 14:19 2.6M 
[ ]125742_S1_M5_CRF_c4591001-1001-10011100.pdf2022-05-04 14:18 2.1M 
[ ]125742_S1_M5_CRF_c4591001-1001-10011135.pdf2022-05-04 14:19 1.4M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031038.pdf2022-05-04 14:18 2.7M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031065.pdf2022-05-04 14:24 2.7M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031111.pdf2022-05-04 14:23 1.7M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031113.pdf2022-05-04 14:23 3.2M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031149.pdf2022-05-04 14:22 1.6M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031186.pdf2022-05-04 14:22 2.4M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031197.pdf2022-05-04 14:20 1.5M 
[ ]125742_S1_M5_CRF_c4591001-1003-10031207.pdf2022-05-04 14:21 1.4M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051047.pdf2022-05-04 14:20 1.4M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051054.pdf2022-05-04 14:17 1.9M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051069.pdf2022-05-04 14:18 1.5M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051214.pdf2022-05-04 14:16 1.4M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051293.pdf2022-05-04 14:16 2.4M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051347.pdf2022-05-04 14:16 1.4M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051387.pdf2022-05-04 14:15 1.7M 
[ ]125742_S1_M5_CRF_c4591001-1005-10051411.pdf2022-05-04 14:15 1.3M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061020.pdf2022-05-04 14:08 1.5M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061040.pdf2022-05-04 14:07 3.8M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061052.pdf2022-05-04 14:08 2.1M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061094.pdf2022-05-04 14:07 2.1M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061098.pdf2022-05-04 14:06 1.6M 
[ ]125742_S1_M5_CRF_c4591001-1006-10061176.pdf2022-05-04 14:07 2.6M 
[ ]125742_S1_M5_bnt162-01-A-adrg.pdf2022-05-04 14:24 891K 
[ ]125742_S1_M5_bnt162-01-S-acrf.pdf2022-05-04 14:26 1.4M 
[ ]125742_S1_M5_bnt162-01-S-csdrg.pdf2022-05-04 14:29 1.2M 
[ ]125742_S1_M5_c4591001-S-Supp-acrf.pdf2022-05-04 14:25 2.9M 
[ ]125742_S1_M5_c4591001-S-acrf.pdf2022-05-04 14:27 2.9M 
[ ]125742_S1_M5_c4591001-S-csdrg.pdf2022-05-04 14:24 1.4M 
[ ]FDA-CBER-2021-5683-0058316-to-0058458_125742_S1_M5_c4591001-A-Supp-define.xml2022-05-04 14:06 692K 
[ ]FDA-CBER-2021-5683-0058459-to-0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl2022-05-04 14:06 183K 
[ ]FDA-CBER-2021-5683-0058479-to-0058594_125742_S1_M5_c4591001-S-define.xml2022-05-04 14:06 904K 
[ ]FDA-CBER-2021-5683-0058595-to-0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl2022-05-04 14:04 183K 
[ ]FDA-CBER-2021-5683-0058615-to-0058652_125742_S1_M5_c4591001-S-Supp-define.xml2022-05-04 14:03 300K 
[ ]FDA-CBER-2021-5683-0058653-to-0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl2022-05-04 14:03 183K 
[ ]FDA-CBER-2021-5683-0058676-to-0058794_125742_S1_M5_bnt162-01-A-define.xml2022-05-04 14:03 828K 
[ ]FDA-CBER-2021-5683-0058795-to-0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl2022-05-04 14:03 183K 
[ ]FDA-CBER-2021-5683-0058829-to-0058954_125742_S1_M5_bnt162-01-S-define.xml2022-05-04 14:03 1.0M 
[ ]FDA-CBER-2021-5683-0058955-to-0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl2022-05-04 14:03 183K 
[ ]FDA-CBER-2021-5683-0059000-to-0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt2022-05-04 14:01 394M 
[ ]FDA-CBER-2021-5683-0065774-to-0066700_125742_S1_M5_c4591001-A-D-addv.xpt2022-05-04 14:03 44M 
[ ]FDA-CBER-2021-5683-0066701-to-0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt2022-05-04 13:59 3.4G 
[ ]FDA-CBER-2021-5683-0123168-to-0126026_125742_S1_M5_c4591001-A-D-adva.xpt2022-05-04 14:00 163M 
Apache/2.4.29 (Ubuntu) Server at avalonlibrary.net Port 443